Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D. +2 more·2011·BMJ
DOI 10.1136/bmj.d813

Cited by (277)

Items 101–200 of 277

  1. Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment
    Marc Schindewolf, Jeffrey Ian Weitz · 2019 · Thrombosis and Haemostasis
  2. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?
    Fionnuala Ní Áinle, Barry Kevane · 2020 · Hematology
  3. Current Knowledge on Factor V Leiden Mutation as a Risk Factor for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
    Daria Eppenberger, Henning Nilius, Betsy Anagnostelis, Carola A. Huber, Michael Nagler · 2022 · Frontiers in Cardiovascular Medicine
  4. Venous Thromboembolism Issues in Women
    Birgit Linnemann, Hannelore Rott, Rainer Bernd Zotz, Christina Hart · 2022 · Hämostaseologie
  5. Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population‐based cohort study
    Inge M van Schouwenburg, Bakhtawar Khan Mahmoodi, Nic J.G.M. Veeger, Hanneke C. Kluin‐Nelemans, Ron T. Gansevoort, Karina Meijer · 2012 · British Journal of Haematology
  6. D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment
    Clive Kearon, Sameer Parpia, F.A. Spencer, Trevor P Baglin, Scott M. Stevens, Kenneth Alan Bauer, Steven R. Lentz, Craig M. Kessler, James D. Douketis, Stephan Moll et al. · 2016 · Thrombosis Research
  7. Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions
    Andrea T. Obi, Sriganesh B. Sharma, Megan A. Elfline, Catherine E. Luke, Abigail R. Dowling, Qing Cai, Andrew Kimball, Mike Holinstat, Livia Stanger, Bethany B. Moore et al. · 2023 · Scientific Reports
  8. Predicting the risk of recurrent venous thromboembolism
    Lisbeth Eischer, Paul Alexander Kyrle · 2013 · Hämostaseologie
  9. Thrombin generation and international normalized ratio in inherited thrombophilia patients receiving thromboprophylactic therapy
    Hilda Luna‐Záizar, Ana Isabel González-Moncada, Emily Lizbeth Padilla-López, Ana Cristina Ramírez Anguiano, Fermín Paúl Pacheco-Moisés, Sandra Fabiola Velasco-Ramírez, María Guadalupe Zavelia Padilla‐Romo, César Borjas-Gutiérrez, Ana Rebeca Jaloma‐Cruz · 2015 · Thrombosis Research
  10. Cis-Segregation of c.1171C>T Stop Codon (p.R391*) in SERPINC1 Gene and c.1691G>A Transition (p.R506Q) in F5 Gene and Selected GWAS Multilocus Approach in Inherited Thrombophilia
    Donato Gemmati, Giovanna Longo, Eugenia Franchini, Juliana Araujo Silva, Ines Gallo, Barbara Lunghi, Stefano Moratelli, Iva Maestri, Maria Luisa Serino, Veronica Tisato · 2021 · Genes
  11. Who should get long-term anticoagulant therapy for venous thromboembolism and with what?
    Marc Alan Rodger, Grégoire Le Gal · 2018 · Hematology
  12. ABO blood group influences risk of venous thromboembolism and myocardial infarction
    Hui Pang, Zhenkun Zong, Lin Hao, Qiumei Cao · 2019 · Journal of Thrombosis and Thrombolysis
  13. Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)
    Remedios Otero, Aurora Solier-López, Verónica Sánchez‐López, Júlia Oto, Elena Arellano, Samira Marín-Romero, Luis Jara‐Palomares, Teresa Elías-Hernández, Isabel Asencio, Isabel Blasco-Esquivias et al. · 2022 · Cancers
  14. Guía de práctica clínica de la ESC 2014 sobre el diagnóstico y el tratamiento de la embolia pulmonar aguda
    Stavros Konstantinides, Adam Torbicki, Giancarlo Agnelli, Nicolas Danchin, David Andrew Fitzmaurice, Nazzareno Galiè, J. Simon R. Gibbs, Menno Volkert Huisman, Marc J.C. Humbert, Nils Kucher et al. · 2014 · Revista Española de Cardiología
  15. Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study
    David Aziz, Leslie Skeith, Marc Alan Rodger, Elham Sabri, Marc Righini, Michael J. Kovacs, Marc Carrier, Susan Rebecca Kahn, Philip Stephen Wells, David R. Anderson et al. · 2021 · Journal of Thrombosis and Haemostasis
  16. Gender Medicine: A New Possible Frontiers of Venous Thromboembolism
    Tiziana Ciarambino, Pietro Crispino, Ombretta Para, Mauro Giordano · 2023 · Stresses
  17. A hybrid knowledge and ensemble classification approach for prediction of venous thromboembolism
    Susan Sabra, Khalid Mahmood Malik, Muhammad Afzal, Vian Sabeeh, Ahmad Charaf Eddine · 2019 · Expert Systems
  18. Thrombophilia
    John A. Heit · 2013 · Elsevier eBooks
  19. Long-term outcome after pregnancy-related venous thrombosis
    Hilde Skuterud Wik, Anne Flem Jacobsen, Per Morten Sandset · 2015 · Thrombosis Research
  20. Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
    Michael Nagler, Sander M. J. van Kuijk, Hugo Ten Cate, Martin H. Prins, Arina J. ten Cate‐Hoek · 2021 · Frontiers in Cardiovascular Medicine
  21. Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink
    Sylvia Kiconco, Alyshah Abdul Sultan, Matthew J. Grainge · 2017 · British Journal of Haematology
  22. Predictive Value of Mean Platelet Volume for Pulmonary Embolism Recurrence
    Ömer Araz, Fadime Sultan Albez, Elif Yılmazel Uçar, Buğra Kerget, Nafiye Yılmaz, Metin Akgün · 2017 · Lung
  23. Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study
    Craig Ian Coleman, W. Frank Peacock, Thomas J. Bunz, Jan Beyer‐Westendorf · 2018 · Thrombosis Research
  24. Lower limb joint replacement in patients with a history of venous thromboembolism
    David J. Allen, G. Sale · 2014 · The Bone & Joint Journal
  25. Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: A systematic review
    Alessandra Bosch, Elizabeth M. Uleryk, Laura Avila · 2023 · Research and Practice in Thrombosis and Haemostasis
  26. Risk factors for recurrent venous thromboembolism in young and middle-aged women
    Maria Ljungqvist, Kristina Sonnevi, Annica Bergendal, Margareta Holmström, Helle Kieler, Gerd Lärfars · 2014 · Thrombosis Research
  27. The incidence of pulmonary thromboembolism in COVID-19 patients admitted to the intensive care unit: a meta-analysis and meta-regression of observational studies
    Jun Jie Ng, Zhen Chang Liang, Andrew M.T.L. Choong · 2021 · Journal of Intensive Care
  28. High detection rates of antithrombin deficiency and antiphospholipid syndrome in outpatients aged over 50 years using the standardized protocol for thrombophilia screening
    Sarah Goldman‐Mazur, Ewa Wypasek, Marek Karpiński, Andrzej Stanisz, Anetta Undas · 2019 · Thrombosis Research
  29. Contraception and Thrombophilia - A statement from the German Society for Gynecological Endo- crinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists (BVF e.V.)
    T. Rabe, Beate Luxembourg, Michael Z. Ludwig, Juergen C Dinger, Rupert Martin Bauersachs, H. Rott, Mueck Ao, Christian Albring · 2011 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  30. How to predict recurrent venous thromboembolism and bleeding? A review of recent advances and their implications
    Johanna Louise I. Burggraaf, Nienke van Rein, Frederikus Albertus Klok, Suzanne C. Cannegieter · 2023 · Polskie Archiwum Medycyny Wewnętrznej
  31. Avoiding implant‐related complications in medically compromised patients with or without unhealthy lifestyle/Elevated oxidative stress
    Gregorio Guabello, Francesco Zuffetti, Andrea Ravidà, Matteo Antonio Deflorian, Giorgio Carta, Muhammad H. A. Saleh, Matteo Serroni, Bernhard Pommer, Georg Watzek, Luca Angelo Francetti et al. · 2023 · Periodontology 2000
  32. Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis
    Jameel Abdulrehman, Carolyne Elbaz, David J. Aziz, Sameer Parpia, Rouhi Fazelzad, Lisbeth Eischer, Marc Alan Rodger, Suzanne C. Cannegieter, Arina J. ten Cate‐Hoek, Michael Nagler et al. · 2022 · British Journal of Haematology
  33. Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach
    Maura Marcucci, Alfonso Iorio, James Demetrios Douketis · 2013 · Current Treatment Options in Cardiovascular Medicine
  34. Epidemiology of recurrent venous thrombosis
    Daniel Dias Ribeiro, Willem M. Lijfering, Sandhi Maria Barreto, Frits Richard Rosendaal, Suely Meireles Rezende · 2011 · Brazilian Journal of Medical and Biological Research
  35. Role of prothrombin 19911 A>G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort study
    Verena Limperger, Gili Kenet, Bettina Kiesau, Max Köther, Malin Schmeiser, Florian Peter Länger, David Juhl, Maria Shneyder, André Franke, Ulrich C. Klostermeier et al. · 2020 · Journal of Thrombosis and Thrombolysis
  36. A current approach to superficial vein thrombosis
    Martin H. Ellis, Simone Fajer · 2012 · European Journal Of Haematology
  37. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study
    Shuai Zhang, Zhenguo Zhai, Yuanhua Yang, Jianguo Zhu, Tuguang Kuang, Wanmu Xie, Suqiao Yang, Fangfang Liu, Juanni Gong, Ying H. Shen et al. · 2014 · International Journal of Cardiology
  38. Factors Associated with elevated Pulmonary Arterial Pressure Levels on the Echocardiographic Assessment in Patients with Prior Pulmonary Embolism
    Remedios Otero, Teresa Elías-Hernández, Luis Jara‐Palomares, Javier Trujillo‐Santos, Laurent Bertoletti, Dolores Nauffal, Justo Ruiz‐Ruiz, Ángeles Blanco-Molina, Manuel Monréal · 2013 · Thrombosis Research
  39. Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management
    Bastian Hass, Jayne Pooley, Adrian E. Harrington, Andreas Clemens, Martin Feuring · 2012 · Thrombosis Journal
  40. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
    Khan, Faizan, Rahman, Alvi, Carrier, Marc, Kearon, Clive, Schulman, Sam, Couturaud, Francis, Prandoni, Paolo, Eichinger, Sabine, Becattini, Cecilia, Agnelli, Giancarlo et al. · 2017 · BMJ Open
  41. Women, thrombosis, and cancer: A gender-specific analysis
    Dominique Farge, Henri Bounameaux, Rupert Martin Bauersachs, Benjamin Brenner · 2017 · Thrombosis Research
  42. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
    Magdalena Maria Piróg, Sławomir Piwowarczyk, Anetta Undas · 2019 · Disease Markers
  43. Trial Protocol: A randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study)
    Jayne Tullett, Ellen T Murray, Linda Nichols, ROGER L. HOLDER, Will Lester, Peter E. Rose, Richard F. Hobbs, David Andrew Fitzmaurice · 2013 · BMC Cardiovascular Disorders
  44. Treatment-free survival after discontinuation of immune checkpoint inhibitors in mNSCLC: a systematic review and meta-analysis
    Yue Hu, Shan Liu, Lixing Wang, Yu Liu, Duohan Zhang, Yinlong Zhao · 2023 · Frontiers in Immunology
  45. [Translated article] Multidisciplinary consensus for the management of pulmonary thromboembolism
    José Luís Lobo, Sergio Alonso, Juan José Arenas-Jiménez, Pere Domènech, Pilar Escribano, Carmen Fernández‐Capitán, Luis Jara‐Palomares, Sònia Jiménez, María Lázaro, Ramón Lecumberri et al. · 2022 · Archivos de Bronconeumología
  46. Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
    Cristiano Bortoluzzi, Enrico Bernardi, Giuseppe Camporese, Franco Noventa, Davide Ceccato, Chiara Tonello, Ngoc Vo Hong, Elena Campello, Chiara Simion, Egidio Imbalzano et al. · 2022 · Life
  47. Sex, gender and venous thromboembolism
    Elena Maria Faioni, Maddalena Loredana Zighetti, Nadia Vozzo · 2018 · Blood Coagulation & Fibrinolysis
  48. South African Society of Anaesthesiologists Perioperative Patient Blood Management Guidelines 2020
    Robert Wise, David Gray Bishop, M Gibbs, Komalan Govender, Michael F. James, Kasandji Freddy Kabambi, Vernon Johan Louw, N Mdladla, L Moipalai, Palesa Motshabi Chakane et al. · 2020 · Southern African Journal of Anaesthesia and Analgesia
  49. Plasma lipopolysaccharide‐binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies
    Søren Beck Jensen, Nadezhda Latysheva, Kristian Hindberg, Thor Ueland · 2022 · Journal of Internal Medicine
  50. A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant – Has venous thromboembolism treatment become safer?
    Brandon Lui, Benjamin Wee, Jeffrey Lai, Zille Khattak, Anna Kwok, Cynthia Donarelli, Prahlad W. Ho, Hui Yin Lim · 2022 · Thrombosis Research
  51. Recurrent Deep Vein Thrombosis After the First Venous Thromboembolism Event: A Single-Institution Experience
    Mohammad Asim, Hassan Ali Saoud Al-Thani, Ayman Ahmed El-Menyar · 2017 · Medical Science Monitor
  52. New insights into treatment of venous thromboembolism
    Stephan Moll · 2014 · Hematology
  53. Male‐specific risk of first and recurrent venous thrombosis: a phylogenetic analysis of the Y chromosome
    Hugoline G. de Haan, Astrid van Hylckama Vlieg, Kristiaan J. van der Gaag, Peter de Knijff, Frits Richard Rosendaal · 2016 · Journal of Thrombosis and Haemostasis
  54. Diagnosis and Anticoagulant Treatment
    Andrew N Nicolaides, Jawed Fareed, A. K. Kakkar, Anthony James Comerota, Samuel Zachary Goldhaber, R. Hull, K. Myers, Meyer Michel Samama, Jane M. Fletcher, Evi Kalodiki et al. · 2013 · Clinical and Applied Thrombosis/Hemostasis
  55. Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single‐centre, single‐surgeon, retrospective analysis
    D. A. L. King, R. E. Pow, David Dickison, Peter R. Vale · 2016 · Internal Medicine Journal
  56. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use
    Ángeles Blanco-Molina, Javier Trujillo‐Santos, Raffaele Pesavento, V. Rosa, Conxita Falgà-Tirado, Carles Tolosa-Vilella, Lucia Mazzolai, Angel Luis Samperiz, Rita Duce, Manuel Monréal · 2017 · Thrombosis Research
  57. Deep Vein Thrombosis and Pulmonary Embolism
    Samuel Zachary Goldhaber · 2013 · Elsevier eBooks
  58. Oral contraceptive use is a provoking factor for venous thromboembolism
    Saskia Middeldorp, Alfonso Iorio · 2017 · BMJ
  59. Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
    Joie Ensor, Richard D Riley, David Moore, Susan E Bayliss, Sue M Jowett, David Andrew Fitzmaurice · 2013 · Systematic Reviews
  60. Scoring Systems for Estimating the Risk of Recurrent Venous Thromboembolism
    Ilaria Nichele, Alberto Tosetto · 2017 · Seminars in Thrombosis and Hemostasis
  61. Thrombophilia
    Jason A. Freed, Kenneth Alan Bauer · 2019 · Elsevier eBooks
  62. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
    Maria A. de Winter, Alicia Uijl, Harry Roger Buller, Marc Carrier, Alexander Thomas Cohen, John‐Bjarne Hansen, Karin A. H. Kaasjager, Ajay K. Kakkar, Saskia Middeldorp, Gary E. Raskob et al. · 2023 · Journal of Thrombosis and Haemostasis
  63. Inherited Thrombophilia: Past, Present, and Future Research
    S. Jorine, Pieter Honkoop · 2011 · InTech eBooks
  64. Venous Thromboembolic Diseases
    Gregory Piazza, Samuel Zachary Goldhaber · 2012 · Oxford University Press eBooks
  65. Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study
    Ken Cohen, David C. Anderson, Sheng Ren, David J. Cook · 2022 · BMJ Open
  66. In-Hospital Management and Follow-Up Treatment of Venous Thromboembolism: Focus on New and Emerging Treatments
    Joshua D. Lenchus, Michelle Biehl, Jorge Luis Cabrera, Alice Gallo de Moraes, Cameron Dezfulian · 2016 · Journal of Intensive Care Medicine
  67. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
    Faizan Khan, Miriam Kimpton, Tobias Tritschler, Grégoire Le Gal, Brian Hutton, Dean A. Fergusson, Marc Alan Rodger · 2019 · Systematic Reviews
  68. Hormone-related thrombosis: duration of anticoagulation, risk of recurrence, and the role of hypercoagulability testing
    Luuk J.J. Scheres, Saskia Middeldorp · 2024 · Hematology
  69. How I treat …
    Frank Moosig, Eva Reinhold‐Keller, Konstanze Holl‐Ulrich, Alfred Christian Feller, Thorsten Alexander Bley, Julia Ulrike Holle, Jochen Zwerina, Peter Lamprecht, Klaus Dalhoff, Nils Venhoff et al. · 2012 · Zeitschrift für Rheumatologie
  70. Optimal duration of anticoagulation in patients with venous thromboembolism.
    Paolo Prandoni, Chiara Piovella, Luca Spiezia, Fabio Dalla Valle, Raffaele Pesavento · 2011 · PubMed Central
  71. Individualised Risk Assessments for Recurrent Venous Thromboembolism: New Frontiers in the Era of Direct Oral Anticoagulants
    Julie Wang, Hui Yin Lim, Prahlad W. Ho · 2021 · Hemato
  72. How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review
    Gualtiero Palareti · 2014 · Expert Review of Hematology
  73. Sex may matter when it comes to the presenting location of deep vein thrombosis
    Vicky Tagalakis · 2018 · Thrombosis Research
  74. Association of rivaroxaban plasma trough concentrations with clinical characteristics and outcomes
    Huizhen Wu, Qiaoling Yu, Panpan Jin, Lijing Huo, Jing An · 2025 · Frontiers in Pharmacology
  75. Seguimiento y tratamiento de la enfermedad tromboembólica venosa a largo plazo: recomendaciones del Grupo de Enfermedad Tromboembólica de la Sociedad Española de Medicina Interna 2024
    M. Martín del Pozo, Miguel Martín Asenjo, Anabel Franco‐Moreno, E. Usandizaga de Antonio, F. Galeano Valle · 2024 · Revista Clínica Española
  76. Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study
    Xiaoyu Cheng, Fei Yan, Xiaomei Xue, Qin He, Tian Liu, Lidan Ma, Ming Dong · 2024 · Thrombosis Journal
  77. Sex Differences in Advanced Therapeutic Interventions for Intermediate- and High-Risk Pulmonary Embolism
    Christiana K Prucnal, Christopher Kabrhel, Nora Horick, Angela F. Jarman · 2024 · Clinical Therapeutics
  78. COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study
    Gualtiero Palareti, Cristina Legnani, Daniela Poli, Walter Ageno, Vittorio Pengo, Sophie Testa, Alberto Tosetto, Paolo Prandoni · 2022 · Haematologica
  79. Venous Thromboembolism Prophylaxis in Arthroscopic Surgery
    Jakub Bryll, Janusz Płomiński · 2013 · Ortopedia Traumatologia Rehabilitacja
  80. Recurrence risk of idiopathic venous thromboembolism
    Anabel Franco‐Moreno, Cristina de Ancos Aracil, María José García Navarro · 2016 · Revista Clínica Española (English Edition)
  81. Venous thromboembolism prophylaxis audit in two Q ueensland hospitals
    Nicholas Phillips, Vernon J Heazlewood · 2012 · Internal Medicine Journal
  82. National guidelines on the management of venous thromboembolism: Joint guideline of the Turkish Society of Cardiovascular Surgery, National Society of Vascular and Endovascular Surgery, and Phlebology Society
    Ahmet Bozkurt, Hakkı Tankut Akay, Tanzer Çalkavur, Mustafa Şırlak, Ozan Onur Balkanay, Emrah Uğuz, Suat Doğancı, Adıl Polat, Serdar Bayrak, Şahin Bozok et al. · 2021 · Turkish Journal of Thoracic and Cardiovascular Surgery
  83. Exploring Risk Factors for Lower Extremity Deep Vein Thrombosis Patients with Co-existing Pulmonary Embolism Based on Multiple Logistic Regression Model
    Jiahong Zu, Tao Yang · 2024 · Clinical and Applied Thrombosis/Hemostasis
  84. Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry
    Paolo Prandoni, Meg Fluharty, Sebastian Schellong, Henri Bounameaux, Sylvia K. Haas, Lorenzo Giovanni Mantovani, Sherif Mohamed Sholkamy, Katsuhiro Kondo, Harry H. Gibbs, Zhi‐Cheng Jing et al. · 2025 · European Journal of Internal Medicine
  85. Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study
    Ida Ehlers Albertsen, Stavros Konstantinides, Gregory Piazza, Samuel Zachary Goldhaber, Torben Bjerregaard Larsen, Mette Søgaard, Peter Brønnum Nielsen · 2022 · TH Open
  86. A Survey of the Clinical Course and Management of Japanese Patients Deficient in Natural Anticoagulants
    Kenji Yokoyama, Tetsuhito Kojima, Yoichi Sakata, Tomio Kawasaki, Hajime Tsuji, Toshiyuki Miyata, Shinichiro Okamoto, Mitsuru Murata · 2012 · Clinical and Applied Thrombosis/Hemostasis
  87. Treatment of Venous Thromboembolism
    Anne E. Rose · 2015 · Springer eBooks
  88. Anticoagulation Beyond 3 to 6 Months: What Does the Data Tell Us?
    Teresa L. Carman · 2018 · Progress in Cardiovascular Diseases
  89. The secondary prevention of venous thromboembolism: Towards an individual therapeutic strategy
    Giovanna Elmi, Attilia M Pizzini, Mauro Silingardi · 2018 · Vascular
  90. Prevention and Treatment of Venous Thromboembolism
    Michael Blake Streiff · 2019 · Elsevier eBooks
  91. Family history of VTE: An easy tool to score the individual risk
    Maurizio Margaglione · 2013 · Thrombosis and Haemostasis
  92. Duration of treatment
    Elie A. Akl, Clive Kearon · 2014
  93. Tromboembolia de pulmón
    María Barca-Hernando, Alberto García‐Ortega, Amaya Martínez Meñaca, M. Purificación Ramírez-Martín, A. Rivas, Andrés Tenes · 2024 · Open Respiratory Archives
  94. Appropriate target range of INR and predictive factors of recurrent thrombosis and bleeding in patients with venous thromboembolism on warfarin
    P. Sae-Lim, Pirun Saelue · 2025 · Scientific Reports
  95. Cardiovascular Adverse Events of JAK versus TNF Inhibitors using the Korean Pharmacovigilance Database
    Jinkyoung Yoon, Seonghae Kim, Bo Ram Yang · 2026 · Cardiology
  96. Riesgo de recurrencia en la enfermedad tromboembólica venosa tras suspender la anticoagulación
    José María Calvo Romero · 2012 · Medicina Clínica
  97. Empfehlungen zur Anwendung der indirekten und direkten Antikoagulanzien zur langfristigen Sekundärprophylaxe nach venösen Thromboembolien
    Knut Kroeger, Jürgen Pleye, S. Pourhassan, Jochen Peter, T. Noppeney · 2018 · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie
  98. Management of Traumatic Brain Injury: Special Considerations for Older Adults
    Megha D. Mandalaywala, Kelly M. Crawford, Shanti M. Pinto · 2019 · Current Physical Medicine and Rehabilitation Reports
  99. Features of pulmonary thromboembolism in women
    Oksana Ya. Vasiltseva, Витт Карина Николаевна, Alexander Cherniavsky · 2021 · Kardiologiia
  100. Cardiovascular mortality and morbidity in pulmonary embolism
    Behnood Bikdeli, Carmen Rodríguez, Alberto García‐Ortega, David Jiménez · 2020 · European Respiratory Society eBooks